Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide
Check out the The free RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide and why we may FDA approved drugs for long COVID quicker than you might think.
Blood, Sex and Inflammation: Did the IMPACC Study Uncover Core Issues in Long COVID and ME/CFS?
The big IMPACC long COVID study findings suggest that inflammation and reduced male sex hormone levels may be playing havoc with the small blood vessels in long COVID -= and ME/CFS
ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3
A Dutch ME/CFS autopsy report findings multiple severe problems in the HPA axis of ME/CFS patients.
RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations
The RECOVER Initiative announces four more clinical trials for long COVID including low dose naltrexone, bariticinib, GLP-1 agonists, and stellate ganglion blockade.
Immune Dysregulation Could be the Tipping Point for Long COVID
Profound immune dysregulation could be the tipping point that turns a COVID-19 patient into a long COVID patient.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
